42 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

4578

Otsuka Holdings
JP¥6,272.001.3%38.1%JP¥3.5tJP¥5,981.82PE28xE6.8%1.9%

JNJ

Johnson & Johnson
US$148.532.6%-8.7%US$360.4bUS$173.60PE18.7xE5.1%3.3%

SAN

Sanofi
€87.701.8%-14.4%€109.5b€107.76PE20.3xE13.6%4.3%

4151

Kyowa Kirin
JP¥2,624.00-0.4%-12.5%JP¥1.4tJP¥3,066.67PE17.3xE3.8%2.2%

3705

YungShin Global Holding
NT$48.55-0.5%7.2%NT$12.9bn/aPE15.6xn/a4.7%

AMGN

Amgen
US$273.013.4%14.3%US$146.7bUS$300.27PE21.8xE8.9%3.3%

8095

Astena Holdings
JP¥485.00-0.4%8.0%JP¥19.2bn/aPE11.9xn/a3.7%

239

Pak Fah Yeow International
HK$2.071.0%45.8%HK$645.1mn/aPE6.1xn/a9.9%

600976

Jianmin Pharmaceutical GroupLtd
CN¥56.493.2%-18.1%CN¥8.6bCN¥87.74PE16.5xE20.7%2.1%

300294

China Resources Boya Bio-pharmaceutical GroupLtd
CN¥31.371.2%-18.1%CN¥16.0bCN¥32.45PE72.2xE30.0%1.0%

MRK

Merck KGaA
€152.353.8%-5.0%€66.2b€182.00PE23.5xE10.0%1.4%

4519

Chugai Pharmaceutical
JP¥4,860.00-4.5%41.7%JP¥8.0tJP¥6,043.57PE24.5xE5.8%1.7%

1681

Consun Pharmaceutical Group
HK$5.725.9%14.9%HK$4.5bHK$7.87PE5.4xE14.4%10.5%

1061

Essex Bio-Technology
HK$2.19-5.2%-38.3%HK$1.2bn/aPE4.5xn/a4.1%

3613

Beijing Tong Ren Tang Chinese Medicine
HK$9.282.8%-41.3%HK$7.8bHK$13.93PE14.4xE15.2%3.6%

IPN

Ipsen
€112.305.6%5.2%€9.3b€124.76PE15xE5.7%1.1%

BIOG B

BioGaia
kr114.50-4.6%17.7%kr11.6bkr140.00PE31.6xE8.9%6.0%

YSPSAH

Y.S.P. Southeast Asia Holding Berhad
RM2.471.6%4.2%RM350.4mn/aPE9.4xn/a4.0%

BIO

Biofarm
RON0.82-0.2%23.4%RON810.0mn/aPE10.5xn/a3.8%

500674

Sanofi India
₹8,149.70-3.8%36.5%₹187.7b₹9,497.60PE31.1xE9.2%2.0%

AHEALTH

Apex Healthcare Berhad
RM3.206.7%20.6%RM2.3bRM2.64PE5.8xE-50.3%7.8%

4577

Daito PharmaceuticalLtd
JP¥2,490.000.04%9.8%JP¥39.0bJP¥3,155.00PE11.9xE12.3%2.4%

2348

Dawnrays Pharmaceutical (Holdings)
HK$1.170.9%-12.0%HK$1.8bn/aPE5xn/a6.8%

REC

Recordati Industria Chimica e Farmaceutica
€49.980.5%21.0%€10.3b€52.14PE26.4xE9.8%2.4%
Page 1 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.